Anís
InvestorDirector, R&D Strategic Insights at Novartis Venture Fund
London, England, United Kingdom
Find your path to Anís
238 people in our graph share verified history with Anís — schools, employers, funds. One of them is your warm intro.
Saran DaviesunlockedAnís: together at Deep Science Ventures (2024)
×4Anís: together at University of Oxford
×2Anís: together at UCB
×3Anís: together at The University of Manchester
About
Biopharma researcher and Oxford Clarendon Scholar with a PhD in breast cancer immunology using single-cell genomics; helps build curative therapeutics companies at DSV.
Experience
- NovartisDirector, R&D Strategic Insightscurrent2026 — presentLondon, England, United Kingdom
- Kindling BioBoard Member2026London Area, United Kingdom
- Stealth Mode BiotechVP Biology & Program Lead2026Cambridge, England, United Kingdom
- Stealth Mode BiotechOrigination Lead2024 — 2025Cambridge, England, United Kingdom
- Flip TherapeuticsCo-Founder & Operating Partner | Board Observer2025 — 2026Cambridge, Massachusetts, United States
- Flip TherapeuticsOrigination Lead2023 — 2024Cambridge, Massachusetts, United States
- Deep Science VenturesPrincipal (Head of Scoping) — Pharmaceuticals2024 — 2026Greater London, England, United Kingdom
- Deep Science VenturesSenior Associate – Pharmaceuticals2022 — 2023Greater London, England, United Kingdom
- Deep Science VenturesAssociate – Pharmaceuticals2022Greater London, England, United Kingdom
- Deep Science VenturesAnalyst – Pharmaceuticals2020 — 2022Greater London, England, United Kingdom
- Deep Science VenturesFellow – Pharmaceuticals2020Greater London, England, United Kingdom
- Self-employedFreelance Consultant2025
- University of OxfordPhD Candidate & Clarendon Scholar – Kennedy Institute2017 — 2021
- University of OxfordMSc Candidate – Nuffield Department of Experimental Medicine2017
- UCBResearch Associate – Immunology Therapeutic Area2015 — 2016Slough, United Kingdom
- Boehringer IngelheimResearch Scientist Trainee – New Therapeutic Concepts (Oncology)2013 — 2014Vienna, Austria
- Lonza BiologicsAuditor – Quality Assurance2012Slough, United Kingdom
- Lonza BiologicsDocument Administrator – Quality Assurance2010 — 2011Slough, England, United Kingdom
Skills & more
Program ManagementLead OptimisationPre-clinical StudiesPharmacokineticsProtein EngineeringTechnology EvaluationProgram LeadershipIn-licensingCRO ManagementCorporate GovernanceBoard of DirectorsBoard of Directors Reporting
+12 more
Corporate FundraisingTerm SheetsConsultancy ServicesFreelancingConsultingStatisticsHigh Performance Computing (HPC)ProgrammingLeadershipTeam ManagementPlatform OperationsTranslational StrategyLanguages English · French · German
- Role of the Board Director (Training Course) — The Chartered Governance Institute UK & Ireland
- Personal Licence — UK Home Office
From Anís's professional profile.
Colleagues at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Frequently asked questions
- Who is Anís?
- Biopharma researcher and Oxford Clarendon Scholar with a PhD in breast cancer immunology using single-cell genomics; helps build curative therapeutics companies at DSV.
- Where does Anís work?
- Anís is Director, R&D Strategic Insights at Novartis Venture Fund.
- Where did Anís go to school?
- Anís studied at University of Oxford (Doctor of Philosophy (DPhil/PhD), Molecular and Cellular Medicine); University of Oxford (Master of Science (MSc), Integrated Immunology); The University of Manchester (Bachelor of Science (BSc) (Hons), Biochemistry with Industrial Experience).
Same school
Also attended University of Oxford1,553
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 1,547 more
Also attended The University of Manchester282
Joel NoyceInvestor at Moonfire VenturesJames BraithwaiteFinancial Controller at NorthzoneFreya Svedberg-KeatingInvestor at MedicxiAndy LeaverOperating Partner at Notion CapitalSimon SegarsExecutive Advisor at Black Opal VenturesHonor de WintonExecutive Assistant at Giant Ventures Global Llp
+ 276 more
Shared employers
Also worked at Deep Science Ventures32
Saran DaviesInvestor at Moonfire VenturesJustin BriggsScientist, entrepreneur, and investor building companies at the nexus of biology, chemistry, and engineeringFrank HicksImpact Committee at EcoEnterprises FundDomFounding Director at Deep Science VenturesSantaDirector, Talent at Deep Science VenturesAhmadExecutive Chairman at Deep Science Ventures
+ 26 more
Also worked at University of Oxford197
Tess van StekelenburgPartner at Lux CapitalGordon RausserAdvisory Board Member at Rembrandt Venture PartnersFrancesco MonacaInvestor at Giant Ventures Global LlpDenise XifaraInvestor at Mercuri.vcLirui DingPrincipal at TRANSCENDAna FernandezInvestment Associate at Nauta Capital
+ 191 more
Also worked at UCB25
Ben PerryInvestor at MedicxiStephen RapeckiInvestor at MedicxiMary PattonScientific Advisory Board at InnoCom Bio EquitiesMiguel ForteAdvisor at Delin VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONSam GrayManaging Partner at Apposite Capital
+ 19 more
Also worked at Boehringer Ingelheim44
Nick FutrellSenior Associate at Northpond VenturesKazuhiko NonomuraPartner at Remiges Ventures, Inc.Drew GonzalesInvestor at Side Door VenturesEmilio Erazo-FischerOperating Partner at Asabys PartnersShinobu SuzukiScientific Advisor at RDiscoveryPeter FarinaExecutive in Residence at Canaan Partners
.jpg)
+ 38 more